Changes in serum DAMPs and cytokines/chemokines during near‐infrared photoimmunotherapy for patients with head and neck cancer
Cancer Medicine · 2024
DOI: 10.1002/cam4.6863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Hiromasa Ishihara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, HMGB1 Protein, Immunotherapy, Cytokines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aichi Cancer Center Joint Research Project on Priority Areas, Japan Society for the Promotion of Science KAKENHI, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Near‐infrared photoimmunotherapy (NIR‐PIT) for head and neck cancer is a recently developed therapy. However, there is limited data on patients receiving NIR‐PIT in real clinical settings.
Methods
Seven NIR‐PIT sessions were administered to five patients with head and neck squamous cell carcinoma (HNSCC). Serum damage‐associated molecular patterns (DAMPs) (HMGB1 and Hsp70 levels), and cytokine and chemokine production, were compared before and after NIR‐PIT.
Results
The serum concentration of HMGB1 increased after NIR‐PIT ( p = 0.031, Wilcoxon test) in all patients except one who did not achieve a clinical response. Chemokines MIP‐1α (CCL3) and MIP‐1β (CCL4) increased significantly 1–3 days after treatment (CCL3, p = 0.0036; CCL4, p = 0.0016, Wilcoxon test). A low pre‐treatment neutrophil‐to‐lymphocyte ratio (NLR) was associated with a better response to therapy and survival.
Conclusions
The release of DAMPs, and cytokine/chemokine production, were detected in the patients' peripheral blood. The baseline NLR may predict patient outcomes in response to NIR‐PIT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan.
- Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.
- Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan.
- Division of Cancer Immunogenomics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
ORCID-Profile: Hirokazu Matsushita
Förderung
- Aichi Cancer Center Joint Research Project on Priority Areas
- Japan Society for the Promotion of Science KAKENHI
- Japan Society for the Promotion of Science
Zitieren
APA
Ishihara, H., Nishikawa, D., Muraoka, D., Masago, K., Beppu, S., Terada, H., Matsushita, H., & Hanai, N. (2024). Changes in serum DAMPs and cytokines/chemokines during near‐infrared photoimmunotherapy for patients with head and neck cancer. Cancer Medicine. https://doi.org/10.1002/cam4.6863
Vancouver
Ishihara H, Nishikawa D, Muraoka D, Masago K, Beppu S, Terada H, et al. Changes in serum DAMPs and cytokines/chemokines during near‐infrared photoimmunotherapy for patients with head and neck cancer. Cancer Medicine. 2024. doi:10.1002/cam4.6863
BibTeX
@article{Ishihara2024,
author = {Ishihara, Hiromasa and Nishikawa, Daisuke and Muraoka, Daisuke and Masago, Katsuhiro and Beppu, Shintaro and Terada, Hoshino and Matsushita, Hirokazu and Hanai, Nobuhiro},
title = {Changes in serum DAMPs and cytokines/chemokines during near‐infrared photoimmunotherapy for patients with head and neck cancer},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.6863}
}
EUVIMED